社区2型糖尿病强化健康教育模式对控制血糖及并发症的研究  

Impact of strengthening health education on controlling blood glucose and complications in community type 2 diabetes patients

作　　者：周薇霞 李祖胜[1] 姜永乐[1] 刘晓红[1] 端木焰 高益群[1] 周延辉[1] 

机构地区：[1]杭州市江干区人民医院内科,浙江杭州310016

出　　处：《中华医院感染学杂志》2011年第22期4785-4787,共3页Chinese Journal of Nosocomiology

摘　　要：目的观察强化健康教育模式对社区2型糖尿病患者的血糖控制及并发症的影响。方法对杭州市江干区社区卫生服务中心在2006年2月-2011年4月诊断为2型糖尿病的630例患者进行回顾性分析,随机分为试验组与对照组,试验组400例,对照组230例,对照组给予常规药物和随访管理,试验组在此基础上强化健康教育模式,时间为1年,比较和分析2组的血糖控制情况、尿微量白蛋白控制情况和并发症的发生情况。结果试验组治疗后空腹血糖为(6.2±2.1)mmol/L,餐后2h血糖为(9.3±2.4)mmol/L;而对照组治疗后空腹血糖为(8.6±2.3)mmol/L,餐后2h血糖为(12.6±3.1)mmol/L,两组比较差异有统计学意义(P<0.05),试验组发生心血管病占70.2%、糖尿病肾病占65.4%,而对照组发生率分别为86.7%、72.2%,差异有统计学意义(P<0.05)。结论强化健康教育模式对社区糖尿病患者的治疗效果明显,明显提高患者血糖自我监测能力,血糖控制率,减少并发症的发生。OBJECTIVE To observe the influence of strengthening health education on controlling blood glucose and complications in community type 2 diabetes patients. METHODS From Feb 2006 to Apr 2011,totally 630 patients diagnosed with type 2 diabetes were retrospectively analyzed and randomly divided into study group（400 cases） and control group（230 cases）.Patients were given health education besides medications and nursing treatment.Comparison and analysis were taken of the two groups of blood sugar control,urine albumin and trace control complications. RESULTS After treatment the FBS of patients was（6.2±2.1）mmol/L,PBS was（9.3±2.4）mmol/L;and the FBS of control group after treatment was（8.6±2.3）mmol/L,PBS was（12.6±3.1）mmol/L.Two groups to compare the t test,（P〈0.05）,was a statistically significant difference.The incidence of Cardiovascular disease in patients was 70.2%,and diabetic nephropathy accounted for 65.4%;incidence in the control group were 86.7% and 72.2%.The chi-square test,（P〈0.05）,was a statistically significant difference. CONCLUSION Strengthening health education has a significant efficacy in the treatment of community diabetes patients,improving self-monitoring capability of blood glucose and the control rate,and reducing the complications.

关 键 词：强化健康教育模式 社区2型糖尿病 血糖控制 并发症 

分 类 号：R197.323[医药卫生—卫生事业管理]